Q Discussing how the coagulation pathways are controlled by inhibitors and fibrinolysis Home, - Demonstrate your understanding of the haemostatic pathways Question: - Demonstrate your understanding of the haemostatic pathways by: a) Discussing how the coagulation pathways are controlled by inhibitors and fibrinolysis Part a Coagulation is an active phenomenon and involves homeostasis (refers to as cessation of bleeding). This arrest (thrombohaemmorhagic homeostats) is controlled by the body by complicated relations between coagulation and the fibrinolytic system along with platelets. General coagulation pathway presents equilibrium between the pro coagulant pathway (which accounts for clot formation) and the mechanisms that inhibit the same further than the injured site. This coagulation process is a cascade of events that leads to hemostasis. The intricate pathway is responsible for fast healing process and prevents the bleeding. The coagulation process is monitored and maintained by various inhibitors, which stops the clot formation, by preventing the formation of thrombus. Disparity in the coagulation system can happens in the perioperative period, which can results in factors such as thrombosis or bleeding. Coagulation pathway includes primary hemostasis which accumulate the platelets and secondary hemostasis as well, which includes two pathways, extrinsic as well as intrinsic, are originately separate but merged at a level, and leads to formation of fibrin activation. Its overall aim is to stabilize the plug of platelet with a fibrin mesh. The commonest pathways activates the fibrinogen into the fibrin. The hemostasis can be done by several clotting factors. The intrinsic pathway consists of factors I (fibrinogen), II (prothrombin), IX (Christmas factor), X (Stuart-Prower factor), XI (plasma thromboplastin) , and XII (Hageman factor). The extrinsic pathway consists of factors I, II, VII (stable factor), and X. Lastly, the common pathway consists of factors I, II, V, VIII, X. Fibrin is significant for hemostasis as both the primary product of the coagulation cascade and the final substrate for fibrinolysis. Fibrinolysis competence is very much influenced by clot structure, Regulation of the fibrinolytic system, like that of the coagulation cascade, is accomplished by varous cofactors, receptors, and inhibitors. b. providing the possible reasons for the patient's results shown in Table 2. Test Result Reference range Units PT/INR 1.9 0.8-1.2 N/A APTT/APR 2.0 0.8 - 1.2 N/A Fibrinogen level 3.0 1.8- 4.5 g/l Part B Increased PT/INR means blood is taking long time to clot. Increased APTT means patient might have a bleeding disorder. It may be due to disturbed and defective intrinsic pathways and deficiency of clotting factors. Related: Protein-amino acid metabolisand energy metabolism Metformin is a commonly used diabetic drug Discussing how the coagulation pathways are controlled
Related :- Q Metformin is a commonly used diabetic drug by270 human biochemistry and metabolism-Based on the literature, fructose 1,6-bisphosphatase (FBPase) is a potential target for metformin. Q How protein/amino acid metabolisand energy metabolism are interlinked BY270 Human Biochemistry and Metabolism - Discuss how protein/amino acid metabolisand energy metabolism are interlinked Q Explain how the evaluation of audit evidence acquired Explain how the evaluation of audit evidence acquired and the conclusions made will affect the overall audit. Q Understanding of the client is crucial to the risk assessment process mpa510 auditing and assurance services - Discuss any gaining an understanding of the client is crucial to the risk assessment process. Q Evaluating the auditor - client relationship at assurance engagement, it's essential that the auditor evaluate whether it is appropriate and prudent for the auditor to continue providing assurance service Q Identify and briefly describe any five aspects of competitive analysis busm067 advanced management accounting - identify and briefly describe any five aspects of competitive analysis Q Role of institutional investor in corporate governance busm060 corporate governance - evaluate the importance and effectiveness of the role of institutional investor in corporate governance and firm performance. Q Companies to engage in Corporate Social Responsibility, CSR, BUSM060 Corporate Governance - Why is it important for companies to engage in Corporate Social Responsibility? Q Discuss the possible solutions to the agency problems busm060 corporate governance- critically discuss the possible solutions to the agency problems that may occur in modern corporations. Q Define agency problem in in the context of modern corporations busm060 corporate governance - define agency problem and explain agency problems in the context of modern corporations with examples.